Previa Medical raises €2.1 million for AI solution to prevent sepsis
BiPER Therapeutics raises €1.25 million in seed funding to develop first-in-class small molecules to treat gastrointestinal cancers
Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC)
DeuterOncology closes €5.65M Series A financing round
Enalees appoints Eric Germain as managing director
Vésale Bioscience receives €1.8M grant from European Innovation Council for PhageDiag project
EverImmune launches phase I clinical trial for its oncobiotic drug candidate in lung and kidney cancer
Genoscience Pharma announces launch of phase 2b clinical trial of ezurpimtrostat to treat hepatocarcinoma in combination with an immune checkpoint inhibitor and an antiangiogenic agent
